Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2023

Type / Class
Equity / Common Stock, no par value
Symbol
CYCN on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q4 0 $0 -$2,000 0
2023 Q3 552 $2,000 $0 $3.62 1
2023 Q2 552 $2,000 -$16,339,696 $3.62 1
2023 Q1 17,239,728 $7,478,416 +$31,217 $0.43 29
2022 Q4 20,826,571 $13,664,576 -$348,638 $0.66 35
2022 Q3 21,234,418 $18,260,273 +$227,247 $0.86 28
2022 Q2 20,881,866 $11,459,174 -$2,242,455 $0.55 29
2022 Q1 23,051,679 $25,583,454 -$789,970 $1.11 42
2021 Q4 23,663,852 $40,697,713 -$4,573,104 $1.72 46
2021 Q3 24,691,427 $75,800,940 +$223,150 $3.07 54
2021 Q2 24,616,229 $96,002,462 +$10,738,104 $3.90 61
2021 Q1 22,365,058 $62,399,018 +$1,331,385 $2.79 67
2020 Q4 20,031,951 $61,295,716 -$6,176,697 $3.06 67
2020 Q3 21,105,661 $128,362,457 +$28,456,389 $6.08 62
2020 Q2 16,455,142 $97,248,887 -$3,017,587 $5.91 63
2020 Q1 16,666,126 $44,162,876 +$8,315,630 $2.65 65
2019 Q4 13,465,254 $36,622,093 -$70,649,340 $2.72 65
2019 Q3 19,485,779 $236,188,655 +$1,641,308 $12.12 82
2019 Q2 19,427,945 $222,445,553 +$212,527,372 $11.45 91
2019 Q1 854,759 $12,665,000 +$12,664,970 $15.46 3